Stoxx Europe 50
|
4 967,21
|
-10,51
|
-0,21 %
|
Analysen zu Stoxx Europe 50-Werten
| 03.02.25 | UniCredit Overweight | JP Morgan Chase & Co. | |
| 03.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.02.25 | Airbus Overweight | JP Morgan Chase & Co. | |
| 03.02.25 | Rheinmetall Overweight | JP Morgan Chase & Co. | |
| 03.02.25 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 03.02.25 | Enel Buy | Goldman Sachs Group Inc. | |
| 03.02.25 | Novartis Hold | Deutsche Bank AG | |
| 03.02.25 | Novartis Kaufen | DZ BANK | |
| 03.02.25 | L'Oréal Hold | Jefferies & Company Inc. | |
| 03.02.25 | Unilever Sell | UBS AG | |
| 03.02.25 | L'Oréal Neutral | UBS AG | |
| 03.02.25 | Nestlé Neutral | UBS AG | |
| 03.02.25 | Novartis Buy | UBS AG | |
| 03.02.25 | Sanofi Buy | UBS AG | |
| 03.02.25 | Airbus Neutral | UBS AG | |
| 03.02.25 | HSBC Holdings Buy | Goldman Sachs Group Inc. | |
| 03.02.25 | HSBC Holdings Hold | Deutsche Bank AG | |
| 03.02.25 | AB InBev Buy | Jefferies & Company Inc. | |
| 31.01.25 | Sanofi Kaufen | DZ BANK | |
| 31.01.25 | Shell Outperform | RBC Capital Markets | |
| 31.01.25 | LVMH Moet Hennessy Louis Vuitton Outperform | RBC Capital Markets | |
| 31.01.25 | Roche Sell | Deutsche Bank AG | |
| 31.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.01.25 | Novartis Buy | UBS AG | |
| 31.01.25 | ABB Sell | Deutsche Bank AG | |
| 31.01.25 | Roche Neutral | UBS AG | |
| 31.01.25 | L'Oréal Neutral | UBS AG | |
| 31.01.25 | Sanofi Buy | UBS AG | |
| 31.01.25 | Shell Buy | UBS AG | |
| 31.01.25 | BBVA Buy | Deutsche Bank AG | |
| 31.01.25 | Intesa Sanpaolo Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Novartis Outperform | Bernstein Research | |
| 31.01.25 | Prosus Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Rheinmetall Buy | Deutsche Bank AG | |
| 31.01.25 | Sanofi Hold | Deutsche Bank AG | |
| 31.01.25 | Novartis Hold | Jefferies & Company Inc. | |
| 31.01.25 | SAP Buy | Goldman Sachs Group Inc. | |
| 31.01.25 | ASML NV Outperform | Bernstein Research | |
| 31.01.25 | ABB Neutral | UBS AG |
HOT STOCKS DER LETZTEN 3 TAGE
| Unilever | 9 |
| AstraZeneca | 5 |
| BP | 4 |
| VINCI | 3 |
| Shell | 3 |
| TotalEnergies | 3 |
| EssilorLuxottica | 3 |
| GSK | 2 |
| Novo Nordisk | 2 |
| London Stock Exchange | 2 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.